Kaleido Biosciences, Inc. KLDO
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.76% | 2.06% | 1.33% | 71.66% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 6.00% | -55.88% | -57.70% | -27.15% | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | -13.16% | -6.61% | -3.41% | 65.36% | |
|
|
|||||
| Total Current Assets | -13.16% | -6.61% | -3.41% | 65.36% | |
| Net Property, Plant & Equipment | -33.05% | -14.18% | -0.75% | 10.90% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -5.51% | |
| Total Assets | -15.51% | -7.30% | -3.09% | 57.18% | |
|
|
|||||
| Total Accounts Payable | 5.21% | -7.20% | -23.96% | 97.06% | |
| Total Accrued Expenses | -9.11% | 7.20% | -22.79% | -35.55% | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 512.91% | 405.46% | 15,843.48% | 10,245.65% | |
| Total Finance Division Other Current Liabilities | -7.66% | -20.57% | -37.86% | 8.07% | |
| Total Other Current Liabilities | -7.66% | -20.57% | -37.86% | 8.07% | |
| Total Current Liabilities | 78.17% | 37.60% | 6.71% | 38.36% | |
|
|
|||||
| Total Current Liabilities | 78.17% | 37.60% | 6.71% | 38.36% | |
| Long-Term Debt | -69.80% | -22.66% | -14.41% | -20.09% | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 12.69% | 14.40% | 16.35% | 18.50% | |
| Total Liabilities | 1.76% | 3.65% | -4.58% | 0.16% | |
|
|
|||||
| Common Stock & APIC | 27.28% | 28.73% | 31.53% | 50.16% | |
| Retained Earnings | -32.93% | -35.42% | -38.99% | -40.13% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -48.25% | -18.67% | -2.06% | 113.48% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -48.25% | -18.67% | -2.06% | 113.48% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -48.25% | -18.67% | -2.06% | 113.48% | |
|
|
|||||